XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value
The following table summarizes the types of assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy:
September 30, 2023December 31, 2022
(in millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Available-for-sale debt securities:
U.S. treasury securities$428 $— $— $428 $410 $— $— $410 
U.S. government agencies securities— 152 — 152 — 35 — 35 
Non-U.S. government securities— 10 — 10 — 34 — 34 
Certificates of deposit— 97 — 97 — 54 — 54 
Corporate debt securities— 1,334 — 1,334 — 1,427 — 1,427 
Residential mortgage and asset-backed securities— 361 — 361 — 333 — 333 
Equity securities:
Money market funds4,240 — — 4,240 3,831 — — 3,831 
Equity investment in Galapagos NV (“Galapagos”)571 — — 571 736 — — 736 
Equity investment in Arcus Biosciences, Inc. (“Arcus”)266 — — 266 286 — — 286 
Other publicly traded equity securities257 — — 257 175 — — 175 
Deferred compensation plan259 — — 259 220 — — 220 
Foreign currency derivative contracts— 67 — 67 — 60 — 60 
Total$6,021 $2,021 $— $8,042 $5,658 $1,943 $— $7,600 
Liabilities:
Liability for MYR GmbH (“MYR”) contingent consideration$— $— $275 $275 $— $— $275 $275 
Deferred compensation plan258 — — 258 220 — — 220 
Foreign currency derivative contracts— — — 42 — 42 
Total$258 $$275 $540 $220 $42 $275 $538 
Summary of Change in Fair Value of Contingent Consideration
The following table summarizes the change in fair value of our contingent consideration liability:
Three Months EndedNine Months Ended
September 30,September 30,
(in millions)2023202220232022
Beginning balance$288 $306 $275 $317 
Changes in valuation assumptions(1)
(2)(30)(19)
Effect of foreign exchange remeasurement(2)
(11)(27)(4)(49)
Ending balance
$275 $249 $275 $249 
________________________________
(1)    Included in Research and development expenses on our Condensed Consolidated Statements of Income. The changes primarily related to increasing discount rates and updated probability rate estimates.
(2)    Included in Other income (expense), net on our Condensed Consolidated Statements of Income.